When Did Patients Receive Radiation Relevant To Nivolumab?

When Did Patients Receive Radiation Relevant To Nivolumab?

User Photo
Mount Sinai Health System

10 months
8 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

William Smith, MD of Mount Sinai answers multiple questions received from colleagues, including: when did patients receive radiation relevant to nivolumab?

______

Among patients with unresectable hepatocellular carcinoma who received combination upfront RT and nivolumab, we found the objective response rate (as determined by mRECIST criteria) to be 35%, substantially increased from historical controls, suggesting that this approach may increase the proportion of patients that would benefit from immune checkpoint inhibition.

Up Next Autoplay